Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

Background Previous studies have assessed the prevalence and characteristics of self-
medication in COVID-19. However, no systematic review has summarized their findings …

Aims Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) and sigma‐1 receptor
agonist, has so far shown promise in the prevention of COVID‐19 progression as an early …

Background Self-medication association with an ongoing pandemic is evident in the studies
conducted throughout the world. To summarize the findings of previous papers, we carried …

Background: We provided a comprehensive evaluation of efficacy of available treatments for
coronavirus disease 2019 (COVID-19). Methods: We searched for candidate COVID-19 …

The issue of bacterial infections in COVID-19 patients has received increasing attention
among scientists. Antibiotics were widely prescribed during the early phase of the pandemic …

This scoping review aimed to explore the prevalence and patterns of global antibiotic use
and bacterial infection in COVID-19 patients from studies published between June 2020 and …

Abstract Introduction: Coronavirus disease 2019 (COVID-19) results in similar clinical
characteristics as bacterial respiratory tract infections and can potentially lead to antibiotic …

Mapping non-canonical cellular pathways affected by approved medications can accelerate
drug repurposing efforts, which are crucial in situations with a global impact such as the …

The aims of this study were to analyze the utilization of antibiotics before (2018, 2019) and
during the COVID-19 pandemic (2020) and the practice of prescribing antibiotics in …